Share

COVID-19 May Pose Blood Clot Risk in Pregnant Women

New Endocrinology cover COVID-19 may increase the risk of blot cots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy, according to a new manuscript published in the Endocrine Society’s journal, Endocrinology. One of the many complications of COVID-19 is the formation of blood clots in previously healthy people. Estrogen increases the chance of blood clots during pregnancy and in women taking birth control pills or hormone...
Share

Research Interrupted: Scientists Are Heeding the Call to Treat COVID-19 Patients

EN0620_cover Endocrine News spoke to two early-career researchers who were called into action to treat COVID-19 patients full time. They share their inspiring stories of how they are coping with their new duties, how their research informed their patients’ care, and what they think the future of healthcare will look like post-pandemic. Endocrine scientists routinely spend...
Share

Virtual Endocrinology: The Rise of Telemedicine During COVID-19

july cover How clinicians treat patients has been drastically reimagined during the COVID-19 pandemic due to social distancing requirements. Since patients still need to see their doctors one way or another, telemedicine has filled the gap and has been embraced by both the healthcare community and patients alike. Chirag R. Kapadia, MD, is an endocrinologist at Phoenix...
Share

Best Laid Plans: Managing COVID-19 in Hospital Settings

A series of papers to be published across a variety of journals provides a potential roadmap for treating COVID-19 patients within a hospital setting. It tells practitioners in these healthcare environments how to prepare for the unexpected. On April 30, an article appeared in the New England Journal of Medicine titled “Best Practices for a...
Share

COVID-19 Damages the Endocrine System

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society. “We explored the previous SARS outbreak caused by the very similar virus SARS-CoV-1 to advise endocrinologists involved in the care of patients with COVID-19,” says Noel Pratheepan Somasundaram...
Share

Expert Opinion: COVID-19 & RAS Blockers

The theoretical threat from blood pressure medicine’s effects on COVID-19 caused many patients on these medications to make panicked calls to their healthcare providers. However, a group of professional associations and researchers moved quickly to counter this fear — and to recommend that patients infected with COVID-19 should continue taking renin-angiotensin system (RAS) blockers in...